Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →Here is the thing nobody tells you when you start a GLP-1: the first 8 weeks are often the hardest part of the entire journey. Your appetite is dropping. Your digestion is slowing. You are relearning how to eat. If nobody coached you through that transition, you would quit — and a lot of people do quit in the first two months, right when the drug is about to do its best work.
We have walked patients through this thousands of times. The side-effect profile is remarkably predictable. Almost everything is manageable. This guide is the playbook we hand people on day one.
Why do GLP-1s cause side effects at all?
GLP-1s work by mimicking a hormone that your body releases after you eat. That hormone does three relevant things: slows stomach emptying, tells your pancreas to release insulin, and signals your brain that you are full. The first one — delayed gastric emptying — is the root of almost every GI side effect people experience. Food that used to clear your stomach in 60–90 minutes now takes 3–5 hours. If you eat the way you used to, you will feel it.
The second source of side effects is dose increase. Your body recalibrates to the current dose over 3–4 weeks; when you step up, you get a smaller version of the "first dose" experience again. This is why a planned, slow titration matters so much.
What's normal in the first 8 weeks?
Here is what we see at each stage. Your timeline may shift by a week or two in either direction, but the pattern is consistent:
| Weeks | What most people experience | What to do |
|---|---|---|
| 1–2 (starter dose) | Mild nausea, early fullness, slight reflux, decreased appetite. Sometimes fatigue. | Eat smaller portions. Hydrate. Protein first at meals. |
| 3–4 | Often a sweet spot — nausea fading, appetite clearly lower, weight starting to drop. | Enjoy it. Do not use this as permission to rush to the next dose. |
| 5 (first step up) | 2–5 days of returned nausea, possible constipation or diarrhea, tiredness. | Bland foods for 3–5 days. Magnesium at night. Walk. |
| 6–8 | Stabilization. Most people feel good. Weight loss is visible. | Build habits you can keep for a year. |
| 9+ (subsequent escalations) | Similar 2–5 day adjustment each time, usually milder. | Repeat the playbook. If any step is rough, hold the dose a month longer. |
Side effects that are almost always benign
- Mild nausea after eating, especially after fatty or fried food. Improves within 1–2 weeks of a dose step.
- Early satiety — feeling full after 5–10 bites. This is the drug working as intended, not a problem.
- Reduced alcohol tolerance and taste change. Most people tolerate much less alcohol on GLP-1s. Wine may taste off. This is real and reported in trials.
- Injection-site mild redness or itching for 12–24 hours. Rotate sites.
- Occasional sulfur-smelling burps. Gross but harmless; usually triggered by fat-heavy meals on a slow-emptying stomach.
The nausea playbook
About 40–55% of people on GLP-1s report some nausea in the first month. Two-thirds of those cases resolve without any change in treatment. Here is what works, in rough order of effectiveness:
- 1Eat protein first. Every meal, start with the protein (eggs, Greek yogurt, chicken, tofu, fish) before carbs or fats. Protein is digested slowly and evenly; it stabilizes nausea better than any other food.
- 2Small and frequent, not three big meals. Aim for 4–5 small feeds of 200–400 calories each. Big plates are nausea triggers on a slow stomach.
- 3Limit fried food, creamy sauces, and very fatty meals for 2 weeks after each step up. Fat is what your stomach empties slowest. It will come back — just not in week 1 post-escalation.
- 4Stay upright after meals. 30 minutes minimum. Lying flat with a partially full stomach is the fastest way to trigger reflux and nausea.
- 5Ginger and cold fluids help. Ginger tea, ginger chews, even flat ginger ale. Ice water with lemon is better tolerated than warm drinks when you are nauseated.
- 6Time your injection. Many patients report less week-1 nausea when they inject in the evening before bed (you sleep through the peak).
- 7Ask about short-term ondansetron (Zofran). 4 mg as needed is a widely used short-term rescue. Not a daily fix — talk to your clinician.
3-min quiz
Having a rough first week?
Talk to a Chia clinician about adjusting your titration. We'd rather slow you down than lose you.
The constipation playbook
Constipation is reported in about 20–25% of GLP-1 users, more often on semaglutide than tirzepatide. It is caused by the same slowed-gut effect that quiets your hunger. The good news: it responds well to a consistent daily routine.
- Hydration: 2.5–3L of water per day, minimum. This is not optional on a GLP-1. Coffee and tea count toward the total.
- Magnesium glycinate or citrate — 300–400 mg at night. Citrate is slightly more laxative; glycinate is gentler and better for sleep. Either is safe for most adults; check with your clinician if you have kidney disease.
- Soluble fiber: 1–2 tablespoons of psyllium husk (Metamucil or similar) daily, in 12 oz of water. Give it 7–10 days to produce effect.
- Daily movement: a 20-minute walk after your largest meal. Physical activity directly stimulates gut motility.
- Mini-rescue: polyethylene glycol (MiraLAX) as needed, 17g in water. OTC, well tolerated, safe short-term.
- Avoid habitual use of stimulant laxatives (senna, bisacodyl) — fine occasionally, not daily.
What about diarrhea?
Diarrhea is more common on tirzepatide (~15–20%) than on semaglutide (~5–10%), and it is usually transient in the first week after a dose change. The playbook:
- Stick to the BRAT framework when it happens (bananas, rice, applesauce, toast) plus broths.
- Avoid sugar alcohols (sorbitol, mannitol, xylitol) — they worsen GLP-1 diarrhea in many people.
- Replace electrolytes — a Pedialyte or a low-sugar LMNT-type packet is often more useful than plain water.
- Loperamide (Imodium) 2 mg after each loose stool, up to 8 mg/day, is safe short-term.
- Persistent diarrhea > 72 hours, bloody stool, or signs of dehydration → call your clinician.
Rare but real: pancreatitis, gallbladder, thyroid
These get the most internet real estate and cause the most patient anxiety. They are real. They are rare. Know the warning signs; do not lose sleep.
Pancreatitis
Reported in roughly 0.1–0.2% of GLP-1 users per year — not meaningfully higher than in the general population in most studies, but specifically warned about on the label. Warning sign: severe, persistent upper-abdominal pain that often radiates to the back, usually with nausea and vomiting, that does not improve in 1–2 hours. Stop the medication and seek urgent care.
Gallbladder disease
Rapid weight loss of any kind raises gallstone risk. GLP-1s compound this. Warning sign: sharp right-upper-quadrant pain, often after a fatty meal, sometimes with fever or jaundice. Ultrasound diagnoses it; cholecystectomy resolves it. Not a reason to avoid the medication, just a reason to know the symptom.
Thyroid C-cell tumors (MTC)
GLP-1s carry a boxed warning from rodent studies. No causal link has been established in humans, but the medication is contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or MEN-2 syndrome. Warning sign: a new lump in the neck, difficulty swallowing, persistent hoarseness. Uncommon, but worth knowing.
Is gastroparesis a real risk?
Gastroparesis — a condition where the stomach empties abnormally slowly — has been reported in GLP-1 users, though case rates are low and most cases resolve when the medication stops. Our practical guidance: if you are unable to keep food down for > 48 hours, have persistent vomiting of undigested food eaten many hours prior, or develop major weight loss beyond your target with severe GI symptoms, pause the medication and see your clinician. This is not the same as "feeling full earlier" — that is the drug working as designed.
When should I call my clinician?
Frequently asked questions
Most last 5–10 days after each dose increase, then fade. The initial starter dose causes the most adjustment because everything is new. Later steps up are usually milder if you escalate slowly.
It is a weekly injection, so the "timing" question is which day you choose. Most patients do well injecting in the evening — you sleep through the steepest plasma rise and tend to have milder day-1 symptoms. Pick a day you can be gentle with yourself and stick to it.
Yes, occasionally — and sometimes that is exactly the right move. If symptoms are rough, it is often better to delay the next injection by a few days than to keep stacking on a slow stomach. Coordinate with your clinician if you are considering holding a dose.
Ondansetron (Zofran) 4 mg as needed is commonly used short-term. Metoclopramide (Reglan) is generally avoided on GLP-1s because it also affects gastric motility. Always coordinate with your clinician before adding a new prescription.
Usually not. It is almost always triggered by a high-fat meal sitting in a slow stomach. If it happens regularly, pull back on fried food and heavy creams for a couple weeks — most people stop noticing it within a dose or two.
You can, but most people find their tolerance is dramatically reduced. One drink feels like three. Some patients report unexpected nausea with any alcohol at all. Proceed cautiously and know that GLP-1s can amplify hypoglycemia risk if you are also on insulin or sulfonylureas.
Mostly the weight loss. Telogen effluvium (temporary shedding) is reported with any rapid loss, including post-pregnancy and post-surgery. It resolves within 3–6 months of weight stabilizing. Adequate protein (1g per pound of goal body weight) and iron help.
Gentle movement helps most symptoms — walking especially. Skip high-intensity sessions when you are actively nauseated; come back to them when you feel steady. Resistance training is the single most important thing you can do to preserve muscle, so do not skip it for weeks on end.
Bottom line
The vast majority of GLP-1 side effects are predictable, manageable, and temporary. The single biggest determinant of how rough your first two months feel is how fast you climb the dose — and that is negotiable. If you are struggling, do not disappear from your clinician; reach out and slow the titration. You will still get to the target dose, just on a schedule your body can handle. The patients who do best are the patients who stay in conversation with their clinical team instead of white-knuckling through symptoms alone.
References
- 1.Wharton S, et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes Obes Metab. 2022;24(1):94-105.
- 2.Jastreboff AM, et al. SURMOUNT-1 Safety Profile of Tirzepatide. Obesity (Silver Spring). 2023.
- 3.Sodhi M, et al. Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss. JAMA. 2023;330(18):1795-1797.
- 4.FDA Prescribing Information: Wegovy (semaglutide) — boxed warning and adverse events, updated 2024.
- 5.FDA Prescribing Information: Zepbound (tirzepatide) — boxed warning and adverse events, updated 2024.
About this article
Dr. Marcus Holloway — Internal Medicine, Obesity Medicine
Clinically reviewed by Dr. Anika Rao — Endocrinology, MD
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
